QUINLAN PAUL T (General Counsel and Secretary) sold 3.3% of their position (1.04K shares) of ORUKA THERAPEUTICS, INC. on the open market
Open‑market sale worth $99.4K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 9/15/2026ACC: 0000907654-26-000095
Officer· General Counsel and Secretary
Since Aug 2024
-1.04K
Net shares
Net seller
$99.4K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
1.04K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−1.04K
Price / share
$95.71
Trade value
$99.44K
% of position
3.3%
9/15/2026
31.03K→30K
Total
Net shares
−1.04K
Net value
-$99.44K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/15/2026 | S · Sale | −1.04K | $95.71 | $99.44K | 3.3% | 31.03K | 30K |
| Total | −1.04K | -$99.44K | ||||||
Derivative Transactions0
No derivative transactions reported